Pharmx Technologies Ltd (PHX) — Capital Reinvestment Ratio
Pharmx Technologies Ltd (PHX) has a Capital Reinvestment Ratio of 0.49x as of June 2024, meaning it reinvests 0% of its operating cash flow (AU$3.21 Million) in capital expenditures (AU$1.58 Million). See PHX equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharmx Technologies Ltd Capital Reinvestment Ratio (2007–2024)
This chart tracks Pharmx Technologies Ltd's Capital Reinvestment Ratio across 16 annual periods. Check Pharmx Technologies Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pharmx Technologies Ltd (2007–2024)
Year-by-year Capital Reinvestment Ratio for Pharmx Technologies Ltd from 2007 to 2024. For live market cap and broader valuation context, see market value of Pharmx Technologies Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.49x | AU$3.21 Million | AU$1.58 Million | ▲ +60.8% |
| 2023 | 0.31x | AU$10.94 Million | AU$3.36 Million | ▼ -83.1% |
| 2022 | 1.81x | AU$2.19 Million | AU$3.98 Million | ▲ +40.2% |
| 2021 | 1.29x | AU$3.16 Million | AU$4.09 Million | ▼ -85.5% |
| 2020 | 8.90x | AU$369.00K | AU$3.28 Million | ▲ +251.6% |
| 2019 | 2.53x | AU$1.35 Million | AU$3.41 Million | ▼ -75.7% |
| 2018 | 10.42x | AU$332.00K | AU$3.46 Million | ▲ +23.4% |
| 2017 | 8.44x | AU$249.00K | AU$2.10 Million | ▲ +11550.3% |
| 2015 | 0.07x | AU$3.53 Million | AU$256.00K | ▲ +661.8% |
| 2014 | 0.01x | AU$5.68 Million | AU$54.00K | ▲ +124.6% |
| 2013 | 0.00x | AU$6.61 Million | AU$28.00K | ▼ -90.6% |
| 2012 | 0.04x | AU$4.67 Million | AU$210.00K | ▲ +6.7% |
| 2011 | 0.04x | AU$3.67 Million | AU$155.00K | ▼ -89.3% |
| 2010 | 0.39x | AU$2.26 Million | AU$890.00K | ▼ -44.1% |
| 2008 | 0.70x | AU$4.46 Million | AU$3.14 Million | ▼ -24.6% |
| 2007 | 0.93x | AU$2.65 Million | AU$2.47 Million | — |